When was Cognivia founded?

Cognivia was founded in 2013 and raised its 1st funding round 11 years after it was founded.

Where is Cognivia located?

Cognivia is headquartered in Mont Saint Guibert, Belgium.

How many employees does Cognivia have?

As of Apr 30, 2026, the latest employee count at Cognivia is 26.

Is Cognivia a funded company?

Cognivia is a funded company, having raised a total of $***** in its 1st and only funding round, a Series B round on Apr 18, 2024.

When was the latest funding round of Cognivia?

Cognivia's latest funding was a $***** Series B round on Apr 18, 2024, with participation from 3 investors. Its primary sector is Biopharma Outsourcing. Globally, the Biopharma Outsourcing sector has seen $828M in funding in 2026 to date.

Where does Cognivia rank among its competitors?

Cognivia ranks 1st amongst 217 active competitors, of which 14 are funded. It stands 3rd in terms of total funding among its competitors. The most recent competitor to raise funding was N-Power Medicine, which secured an undisclosed amount in Jul, 2024.

Who are the top competitors of Cognivia?

Cognivia's top competitors include Clario, N-Power Medicine and CRYOPDP. Among them, N-Power Medicine secured the most recent funding round in July, 2024.

Cognivia - 2026 Company Profile, Team, Funding, Competitors & Financials

Cognivia is a series B company based in Mont Saint Guibert (Belgium), founded in 2013. It operates as a Provider of data modeling and patient insights for clinical trial optimization. Cognivia has raised $16.5M in funding. The company has 217 active competitors, including 14 funded and 13 that have exited. Its top competitors include companies like Clario, N-Power Medicine and CRYOPDP.

Company Details

Provider of data modeling and patient insights for clinical trial optimization. It offers solutions to predict patient behavior and drug responses, aiming to improve the predictability of clinical trials. The company focuses on reducing data variability caused by placebo response and patient heterogeneity to demonstrate treatment efficacy. It also provides tools to predict patient nonadherence and dropout risk, helping to strengthen patient engagement and improve study power for more informed clinical development decisions.

Website: cognivia.com
Social
Email ID: *****@cognivia.com
Phone Number: +32 **********

Key Metrics

Founded Year

2013

Location

Mont Saint Guibert, Belgium

Stage

Series B

Total Funding

$16.5M in 1 round

Latest Funding Round

Series B, Apr 18, 2024, $*****

Investors

Wallonie Entreprendre & 3 more

Ranked

1^st among 217 active competitors

Employee Count

26 as on Apr 30, 2026

Similar Companies

Clario & 237 more

View Cognivia's full profile

Cognivia is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Tools4patient SA CIN: 0534.842.954 , Belgium, Active	Dec 31, 2012	-	11 (As on Dec 31, 2018)	-

Cognivia has raised a total funding of $16.5M over 1 round. Its latest funding round was a Series B round on Apr 18, 2024 for $*****. 3 investors participated in its latest round. Cognivia has 4 institutional investors.

Here is the list of recent funding rounds of Cognivia:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Apr 18, 2024	7088154	Series B	6935288	9571224	2222399	5304286

Access funding benchmarks and valuations. Sign up today!

View details of Cognivia's funding rounds and investors

Cognivia's employee count trend

Cognivia has 26 employees as of Apr 26. Here is Cognivia's employee count trend over the years:

Uncover Cognivia's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Cognivia include Clario, N-Power Medicine and CRYOPDP. Here is the list of Top 10 competitors of Cognivia, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Cognivia 2013, Mont Saint Guibert (Belgium), Series B	Provider of data modeling and patient insights for clinical trial optimization	$16.5M	Wallonie Entreprendre, Vesalius Biocapital Partners ... & 2 others	52/100
2nd	Clario 1972, Philadelphia (United States), Acquired	CRO focused on providing clinical trial supply services for biopharma sector	-	Athyrium Capital Management, ATP Private Equity Partners ... & 7 others	50/100
3rd	N-Power Medicine 2021, Redwood City (United States), Series B	Provider of clinical trial services	$72M	Merck Global Health Innovation Fund	48/100
4th	CRYOPDP 1992, Tremblay-en-France (France), Acquired	Provider of cold chain clinical trial logistics services	-	-	47/100
5th	Dr. Vince Clinical Research 2021, Overland Park (United States), Unfunded	CRO focused on clinical trial development services	-	-	43/100
6th	SFJ Pharmaceuticals 2008, Pleasanton (United States), Late Stage	Specialty pharmaceutical company based on partnering model	$69.5M	Abingworth, Blackstone	42/100
7th	PCM Trials 2008, Denver (United States), Unfunded	Provider of research and decentralized clinical trials	-	-	40/100
8th	Myonex 2020, Norristown (United States), Unfunded	CRO focused on providing clinical trial supply solutions	-	-	39/100
9th	Ikris Pharma Network 2014, Noida (India), Unfunded	Provider of clinical trial sourcing services	-	-	39/100
10th	Medsir 2012, Barcelona (Spain), Unfunded	Clinical research organization specializing in the design and management of strategic clinical trials in oncology	-	-	39/100